"Cancer models" trang 1 - tải miễn phí từ tailieunhanh
Ebook Patient derived tumor xenograft models - Promise, potential and practice: Part 1

Ebook Patient derived tumor xenograft models - Promise, potential and practice: Part 1
230    1    1
Ebook Patient derived tumor xenograft models - Promise, potential and practice: Part 2

Ebook Patient derived tumor xenograft models - Promise, potential and practice: Part 2
259    1    1
A comparative study of survival models for breast cancer prognostication revisited: The benefits of multi-gene models

A comparative study of survival models for breast cancer prognostication revisited: The benefits of multi-gene models
9    53    1
Stage of breast cancer at diagnosis in New Zealand: Impacts of socio-demographic factors, breast cancer screening and biology

Stage of breast cancer at diagnosis in New Zealand: Impacts of socio-demographic factors, breast cancer screening and biology
9    82    1
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
13    81    1
Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models
9    54    1
An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain
9    42    2
Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: A comparison of ectopic and orthotopic tumours

Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: A comparison of ectopic and orthotopic tumours
10    49    1
Polygenic risk prediction models for colorectal cancer: A systematic review

Polygenic risk prediction models for colorectal cancer: A systematic review
21    38    3
Advancing preclinical cancer models to assess clinically relevant outcomes

Advancing preclinical cancer models to assess clinically relevant outcomes
3    4    1
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
9    2    1
HORMONE THERAPY IN BREAST AND PROSTATE CANCER

HORMONE THERAPY IN BREAST AND PROSTATE CANCER
423    69    0
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
12    85    0
Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models

Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models
16    63    1
On the use of flexible excess hazard regression models for describing long-term breast cancer survival: A case-study using population-based cancer registry data

On the use of flexible excess hazard regression models for describing long-term breast cancer survival: A case-study using population-based cancer registry data
10    62    1
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer

Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
11    34    1
Identifying important microbial and genomic biomarkers for differentiating right- versus left-sided colorectal cancer using random forest models

Identifying important microbial and genomic biomarkers for differentiating right- versus left-sided colorectal cancer using random forest models
11    1    1
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models

Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models
11    52    1
The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models

The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models
13    30    1
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: Progress and challenges

Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: Progress and challenges
11    3    1